McSwain, DLA Piper's Appellate Head Spar Over Legality of Safe Injection Site
U.S. Attorney William McSwain said the introduction of safe injection sites invited unsafe and illegal drug use, while a DLA Piper lawyer representing the nonprofit company seeking to manage the site said there was no intent to promote drug abuse, and that it was aimed at creating access to medical care.
September 05, 2019 at 06:52 PM
5 minute read
Arguments in Philadelphia federal court Thursday over whether a proposed supervised injection site would violate the Controlled Substances Act focused on the purpose of opening such sites and what consequences—both intended and unintended—might arise.
In nearly two hours of arguments before U.S. District Judge Gerald A. McHugh of the Eastern District of Pennsylvania, U.S. Attorney William McSwain said the introduction of safe injection sites invited unsafe and illegal drug use, while a DLA Piper lawyer representing the nonprofit company seeking to manage the site said there was no intent to promote drug abuse, and that it was aimed at creating access to medical care.
According to Ilana Eisenstein, DLA Piper's appellate co-chair, who represented Safehouse, which seeks to open the country's first safe injection site, its purpose is akin to that of emergency medical staff and first responders, who provide lifesaving medical care to overdose victims. But McSwain said the unintended purpose of the site would be to allow, and even promote, unlawful drug use.
McSwain, whose office sued Safehouse in February seeking a declaratory judgment saying the proposed site—where heroin users would inject the drug under the supervision of medical staff—is illegal under the Controlled Substances Act, said he was skeptical of the assertion that the purpose of the site is to dissuade people from drug use, and said that, under the law, the court also needed to focus on the "necessary preconditions" that go along with the stated purpose. In this case, those preconditions would be inviting people onto the group's property to do drugs.
"I think that would be engaging in make-believe for us to say that the purpose of Safehouse is to get people to stop using drugs," McSwain said. "That's going down a path that's anti-factual."
When McHugh asked whether McSwain thought the group's purpose was to promote drug use, McSwain said he thought that could be part of it.
"I think it is inevitable that they are in fact promoting it," McSwain said.
McSwain further contended that there are other services in the city that promote addiction treatment and medical care, but the only difference is that Safehouse would be inviting addicts who use their services to inject heroin on their property.
"I think the hubris here is pretty astonishing," McSwain said. "They're saying, we know better, but we're going to do it anyways."
The arguments came more than a week after the court held an evidentiary hearing about the ethics and policy implications of opening a safe injection site. But the hearing Thursday focused solely on each side's interpretation of the Controlled Substances Act, including the relevant case law and legislative intent.
The Controlled Substances Act makes it illegal to "knowingly open, lease, rent, use, or maintain any place" for the use of controlled substances and has historically been used to prosecute houses where drugs were sold.
The feds' suit, which is the first of its kind in the nation and may presage the way federal prosecutors and courts will address an issue that is being debated in several cities across the country, specifically takes issue with Safehouse's stated plan to operate a "consumption room," where medical staff would oversee heroin injections.
It is Safehouse's position that the site would help stem the recent increase of opioid-related deaths and reduce the spread of disease, but McSwain has contended that the site clearly violates the law. In announcing the lawsuit, he dismissed the notion that the law makes any distinction for doctors, nurses or others who do not sell drugs, but are there to provide medical oversight.
During the argument session, Eisenstein said the purpose of the site is to save lives, and she disputed that drug use or promotion would be a necessary precondition.
"There would be nothing better than for Safehouse to not be needed," she said, adding later in the argument, "The hope is they come to the registration desk and they go right into treatment, and they never reach that place where they need to be a part of the supervised consumption site. But unfortunately, that's not realistic."
The government's reading of the law, Eisenstein said, would also create criminal liability for anyone who owns or manages a property any time there is drug use going on. Eisenstein further contended that, although Congress never expressly addressed safe injection sites, medical care is regulated in such a way that it needs to be specifically prohibited for the courts to determine it to be illegal.
After McHugh asked Eisenstein to address the argument that the issue would better be left to Congress, Eisenstein said, "There's no need to amend the statute to do what Congress has not prohibited."
"It is not a gap in the statute," she said. "It is a gap in care."
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllPa. High Court to Weigh Parent Company's Liability for Dissolved Subsidiary's Conduct
3 minute readPa. Supreme Court Taps New Philadelphia Family Division Administrative Judge
3 minute readFrom 'Confusing Labyrinth' to Speeding 'Roller Coaster': Uncertainty Reigns in Title IX as Litigators Await Second Trump Admin
6 minute readTrending Stories
- 1Del. Court Holds Stance on Musk's $55.8B Pay Rescission, Awards Shareholder Counsel $345M
- 2Another Senior Boeing Attorney Exits, This One for CLO Post at Jet-Maintenance Company
- 3Bridge the Communication Gap: The Benefits of Having (and Being) a Bilingual Mediator
- 4CFIUS Is Locked and Loaded, but What Lies Ahead for CFIUS Enforcement Activity?
- 5Deluge of Trump-Leary Government Lawyers Join Job Market, Setting Up Free-for-All for Law Firm, In-House Openings
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250